Lupin gets US FDA nod for heart disease drug
Drug major Lupin said it has received US health regulator’s approval to market generic version of Gilead Sciences, Inc’s Ranexa tablets, a drug used to treat heart disease, in the American market. The...
View ArticleLupin stock up on Glumetza US FDA approval
Drug major Lupin announced receiving the go-ahead from US FDA for its Glumetza drug. Lupin received final approval for its Metformin Hydrochlonde extended release tablet (HCI ER) 500 mg and 1000 mg...
View ArticleLupin gets USFDA nod for diabetes drug
Drug major Lupin said it has received US health regulator’s approval to sell its generic version of Glumetza HCl ER Tablets, a diabetes drug, in the American market. The company’s US-based subsidiary...
View ArticleLupin expects sales to grow by around 25 per cent in next 3 yrs
Drug maker Lupin expects its sales to continue growing at around 25 per cent globally for the next three years with contributions coming from all the markets where it is present. Lupin, which already...
View ArticleLupin shows record sales and profits in Quarter III results
Pharma Major, Lupin Ltd reported its performance for the third quarter ended December 31, 2012. These unaudited results were taken on record by the Board of Directors at a meeting in Mumbai. The Net...
View Article
![[-100%] Commodity Intelligence – (Android Apps)](http://play-lh.googleusercontent.com/j67-qJvmnn4xnVlYVZ9ZhtZUJIgwjKekJGoKQT6D1KHcWGZxtQaFroummEvwV17na7tyh1pGbbeWCRdWtTKqeg=w950-h950)
